Atlas Trials

MAP-guided Preemptive Therapy of aGvHD

Clinical trial NCT05368181 · UNKNOWN

Trial details

NCT number
NCT05368181
Sponsor
Sichuan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
GVHD,AcuteStem Cell Transplant Complications
Start date
2022-05-01
Primary completion
2023-01-30
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.